Literature DB >> 20126989

REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells.

Louisa Rafa1, Anne-Frédérique Dessein, Louise Devisme, David Buob, Stéphanie Truant, Nicole Porchet, Guillemette Huet, Marie-Pierre Buisine, Thécla Lesuffleur.   

Abstract

REG4, the latest member of the regenerating gene family, is overexpressed in inflammatory bowel diseases and gastrointestinal carcinomas. To date, its pathophysiologic role has not been well established. Using HT-29 models, we previously identified REG4 as being overexpressed in colorectal tumor cells displaying a drug-resistance phenotype; some also displayed invasive properties. Thus, we investigated the potential functions of REG4 in biological processes involved in colorectal tumor progression such as cell proliferation, migration and invasion. Colon cancer cells secreting REG4 (HT29-5M21, HT29-5F7 and HT29/REG4-8) or not (HT-29, HT29/CT1 and Caco-2/TC7) were used to analyze the autocrine and paracrine effects of REG4. REG4 was continuously secreted into the culture medium of colon cancer cells. REG4 stimulated cell growth in a paracrine manner after 24 h of treatment. Notably, REG4 promoted migration and invasion of tumor cells in both an autocrine and paracrine manner, and these effects were significantly decreased by concomitant treatment with an anti-REG4 antibody. Using pharmacological inhibitors, we showed that PI3K/Akt, PKAs, PKCs and Rho-like GTPases, but not MAPK, are involved in REG4 invasion signals. In addition, REG4 expression was found to be increased in tissues harboring proliferation and migration properties such as the developing intestine and tissues from inflammatory bowel disease, hyperplastic polyps, adenoma and colorectal cancers. In various situations, REG4 expression was not confined to proliferating cells, regenerating cells or cells of the invasive front of metastatic tumors, suggesting that extracellular REG4 may act on epithelial cells in a paracrine manner. Altogether, our results indicate that REG4 is a multifunctional secreted protein which acts on colorectal cancer cells in an autocrine and paracrine manner. According to its biological functions and tissue expression, REG4 may play an important role in the development and progression of colorectal cancer, as well as in intestinal morphogenesis and epithelium restitution.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20126989     DOI: 10.3892/ijo_00000544

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  17 in total

1.  Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.

Authors:  Anuli Uzozie; Paolo Nanni; Teresa Staiano; Jonas Grossmann; Simon Barkow-Oesterreicher; Jerry W Shay; Amit Tiwari; Federico Buffoli; Endre Laczko; Giancarlo Marra
Journal:  Mol Cell Proteomics       Date:  2014-02-24       Impact factor: 5.911

Review 2.  Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers.

Authors:  Masakatsu Numata; Takashi Oshima
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

3.  Regenerating gene family member 4 promotes growth and migration of gastric cancer through protein kinase B pathway.

Authors:  Jiamiao Huang; Ya Yang; Jian Yang; Xian Li
Journal:  Int J Clin Exp Med       Date:  2014-09-15

4.  Poly (ADP-ribose) transferase/polymerase-1-deficient mice resistant to age-dependent decrease in β-cell proliferation.

Authors:  Lei Gong; Fu-Qiang Liu; Ying Wang; Xin-Guo Hou; Wei Zhang; Wei-Dong Qin; Yun Zhang; Li Chen; Ming-Xiang Zhang
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

5.  [Bushen Huatan recipe for treatment of polycystic ovary syndrome: therapeutic mechanism based on network pharmacology and molecular docking].

Authors:  M Gao; Y Hong; M Cui; J Huang; Y Tan; X Nie
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

Review 6.  The Potential Role of REG Family Proteins in Inflammatory and Inflammation-Associated Diseases of the Gastrointestinal Tract.

Authors:  Chao Sun; Xiaoyu Wang; Yangyang Hui; Hirokazu Fukui; Bangmao Wang; Hiroto Miwa
Journal:  Int J Mol Sci       Date:  2021-07-03       Impact factor: 5.923

7.  Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.

Authors:  Moritz Schütte; Thomas Risch; Nilofar Abdavi-Azar; Karsten Boehnke; Dirk Schumacher; Marlen Keil; Reha Yildiriman; Christine Jandrasits; Tatiana Borodina; Vyacheslav Amstislavskiy; Catherine L Worth; Caroline Schweiger; Sandra Liebs; Martin Lange; Hans-Jörg Warnatz; Lee M Butcher; James E Barrett; Marc Sultan; Christoph Wierling; Nicole Golob-Schwarzl; Sigurd Lax; Stefan Uranitsch; Michael Becker; Yvonne Welte; Joseph Lewis Regan; Maxine Silvestrov; Inge Kehler; Alberto Fusi; Thomas Kessler; Ralf Herwig; Ulf Landegren; Dirk Wienke; Mats Nilsson; Juan A Velasco; Pilar Garin-Chesa; Christoph Reinhard; Stephan Beck; Reinhold Schäfer; Christian R A Regenbrecht; David Henderson; Bodo Lange; Johannes Haybaeck; Ulrich Keilholz; Jens Hoffmann; Hans Lehrach; Marie-Laure Yaspo
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

8.  Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon.

Authors:  Nobuo Sasaki; Norman Sachs; Kay Wiebrands; Saskia I J Ellenbroek; Arianna Fumagalli; Anna Lyubimova; Harry Begthel; Maaike van den Born; Johan H van Es; Wouter R Karthaus; Vivian S W Li; Carmen López-Iglesias; Peter J Peters; Jacco van Rheenen; Alexander van Oudenaarden; Hans Clevers
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

9.  REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation.

Authors:  Atle van Beelen Granlund; Ann Elisabet Østvik; Øystein Brenna; Sverre H Torp; Bjørn I Gustafsson; Arne Kristian Sandvik
Journal:  Cell Tissue Res       Date:  2013-03-22       Impact factor: 5.249

10.  In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.

Authors:  Che-Ming Liu; Chia-Ling Hsieh; Yun-Chi He; Sen-Jei Lo; Ji-An Liang; Teng-Fu Hsieh; Sajni Josson; Leland W K Chung; Mien-Chie Hung; Shian-Ying Sung
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.